Diagnosis of neurogenetic disorders : : contribution of next generation sequencing and deep phenotyping / / special issue editor, Alisdair McNeill.

The contribution of genomic variants to the aetiopathogenesis of both paediatric and adult neurological disease is being increasingly recognized. The use of next-generation sequencing has led to the discovery of novel neurodevelopmental disorders, as exemplified by the deciphering developmental diso...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Year of Publication:2019
Language:English
Physical Description:1 electronic resource (94 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993548231904498
ctrlnum (CKB)4100000010106204
(oapen)https://directory.doabooks.org/handle/20.500.12854/45005
(EXLCZ)994100000010106204
collection bib_alma
record_format marc
spelling Diagnosis of neurogenetic disorders : contribution of next generation sequencing and deep phenotyping / special issue editor, Alisdair McNeill.
Diagnosis of Neurogenetic Disorders
MDPI - Multidisciplinary Digital Publishing Institute 2019
1 electronic resource (94 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
The contribution of genomic variants to the aetiopathogenesis of both paediatric and adult neurological disease is being increasingly recognized. The use of next-generation sequencing has led to the discovery of novel neurodevelopmental disorders, as exemplified by the deciphering developmental disorders (DDD) study, and provided insight into the aetiopathogenesis of common adult neurological diseases. Despite these advances, many challenges remain. Correctly classifying the pathogenicity of genomic variants from amongst the large number of variants identified by next-generation sequencing is recognized as perhaps the major challenge facing the field. Deep phenotyping (e.g., imaging, movement analysis) techniques can aid variant interpretation by correctly classifying individuals as affected or unaffected for segregation studies. The lack of information on the clinical phenotype of novel genetic subtypes of neurological disease creates limitations for genetic counselling. Both deep phenotyping and qualitative studies can capture the clinical and patient’s perspective on a disease and provide valuable information. This Special Issue aims to highlight how next-generation sequencing techniques have revolutionised our understanding of the aetiology of brain disease and describe the contribution of deep phenotyping studies to a variant interpretation and understanding of natural history.
English
Creative Commons NonCommercial-NoDerivs https://creativecommons.org/licenses/https://mdpi.com/books/pdfview/book/1735
Unrestricted online access star
Description based on online resource ; title from PDF title page (viewed on 03/18/2021)
Neurogenetics.
polymicrogyria
neurodegenerative disease
next generation sequencing (NGS)
inborn error of metabolism
genetic biomarker
deep learning
TUBA1A
Alzheimer's disease (AD)
ataxia
risk prediction
p.(Arg2His)
movement science
tubulin
R2H
diagnosis
machine learning
metal storage disorders
amyotrophic lateral sclerosis (ALS)
glucocerebrosidase
Parkinsonism
cerebellar hypoplasia
Gaucher disease
disease phenotyping
tubulinopathy
Parkinson's disease (PD)
dementia
Parkinson's disease
3-03921-610-4
McNeill, Alisdair, editor.
language English
format eBook
author2 McNeill, Alisdair,
author_facet McNeill, Alisdair,
author2_variant a m am
author2_role TeilnehmendeR
title Diagnosis of neurogenetic disorders : contribution of next generation sequencing and deep phenotyping /
spellingShingle Diagnosis of neurogenetic disorders : contribution of next generation sequencing and deep phenotyping /
title_sub contribution of next generation sequencing and deep phenotyping /
title_full Diagnosis of neurogenetic disorders : contribution of next generation sequencing and deep phenotyping / special issue editor, Alisdair McNeill.
title_fullStr Diagnosis of neurogenetic disorders : contribution of next generation sequencing and deep phenotyping / special issue editor, Alisdair McNeill.
title_full_unstemmed Diagnosis of neurogenetic disorders : contribution of next generation sequencing and deep phenotyping / special issue editor, Alisdair McNeill.
title_auth Diagnosis of neurogenetic disorders : contribution of next generation sequencing and deep phenotyping /
title_alt Diagnosis of Neurogenetic Disorders
title_new Diagnosis of neurogenetic disorders :
title_sort diagnosis of neurogenetic disorders : contribution of next generation sequencing and deep phenotyping /
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2019
physical 1 electronic resource (94 p.)
isbn 3-03921-611-2
3-03921-610-4
callnumber-first Q - Science
callnumber-subject QP - Physiology
callnumber-label QP356
callnumber-sort QP 3356.22
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 612 - Human physiology
dewey-full 612.8
dewey-sort 3612.8
dewey-raw 612.8
dewey-search 612.8
work_keys_str_mv AT mcneillalisdair diagnosisofneurogeneticdisorderscontributionofnextgenerationsequencinganddeepphenotyping
AT mcneillalisdair diagnosisofneurogeneticdisorders
status_str n
ids_txt_mv (CKB)4100000010106204
(oapen)https://directory.doabooks.org/handle/20.500.12854/45005
(EXLCZ)994100000010106204
carrierType_str_mv cr
is_hierarchy_title Diagnosis of neurogenetic disorders : contribution of next generation sequencing and deep phenotyping /
author2_original_writing_str_mv noLinkedField
_version_ 1797653505407713280
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03649nam-a2200673z--4500</leader><controlfield tag="001">993548231904498</controlfield><controlfield tag="005">20240424230642.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03921-611-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010106204</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/45005</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010106204</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">QP356.22</subfield></datafield><datafield tag="082" ind1="0" ind2="0"><subfield code="a">612.8</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Diagnosis of neurogenetic disorders :</subfield><subfield code="b">contribution of next generation sequencing and deep phenotyping /</subfield><subfield code="c">special issue editor, Alisdair McNeill.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Diagnosis of Neurogenetic Disorders</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (94 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The contribution of genomic variants to the aetiopathogenesis of both paediatric and adult neurological disease is being increasingly recognized. The use of next-generation sequencing has led to the discovery of novel neurodevelopmental disorders, as exemplified by the deciphering developmental disorders (DDD) study, and provided insight into the aetiopathogenesis of common adult neurological diseases. Despite these advances, many challenges remain. Correctly classifying the pathogenicity of genomic variants from amongst the large number of variants identified by next-generation sequencing is recognized as perhaps the major challenge facing the field. Deep phenotyping (e.g., imaging, movement analysis) techniques can aid variant interpretation by correctly classifying individuals as affected or unaffected for segregation studies. The lack of information on the clinical phenotype of novel genetic subtypes of neurological disease creates limitations for genetic counselling. Both deep phenotyping and qualitative studies can capture the clinical and patient’s perspective on a disease and provide valuable information. This Special Issue aims to highlight how next-generation sequencing techniques have revolutionised our understanding of the aetiology of brain disease and describe the contribution of deep phenotyping studies to a variant interpretation and understanding of natural history.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="540" ind1=" " ind2=" "><subfield code="a">Creative Commons NonCommercial-NoDerivs</subfield><subfield code="u">https://creativecommons.org/licenses/https://mdpi.com/books/pdfview/book/1735</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource ; title from PDF title page (viewed on 03/18/2021)</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Neurogenetics.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polymicrogyria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurodegenerative disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">next generation sequencing (NGS)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inborn error of metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genetic biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">deep learning</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TUBA1A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Alzheimer's disease (AD)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ataxia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">risk prediction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">p.(Arg2His)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">movement science</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tubulin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">R2H</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diagnosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">machine learning</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metal storage disorders</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">amyotrophic lateral sclerosis (ALS)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glucocerebrosidase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Parkinsonism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cerebellar hypoplasia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Gaucher disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disease phenotyping</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tubulinopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Parkinson's disease (PD)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dementia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Parkinson's disease</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03921-610-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McNeill, Alisdair,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-04-26 03:15:43 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-02-01 22:26:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338822060004498&amp;Force_direct=true</subfield><subfield code="Z">5338822060004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338822060004498</subfield></datafield></record></collection>